Correlation Between Shivalik Bimetal and Krebs Biochemicals

Can any of the company-specific risk be diversified away by investing in both Shivalik Bimetal and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shivalik Bimetal and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shivalik Bimetal Controls and Krebs Biochemicals and, you can compare the effects of market volatilities on Shivalik Bimetal and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shivalik Bimetal with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shivalik Bimetal and Krebs Biochemicals.

Diversification Opportunities for Shivalik Bimetal and Krebs Biochemicals

-0.61

Correlation Coefficient

Shivalik Bimetal  Krebs Biochemicals

Excellent diversification

The 3 months correlation between Shivalik and Krebs is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Shivalik Bimetal Controls and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Shivalik Bimetal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shivalik Bimetal Controls are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Shivalik Bimetal i.e., Shivalik Bimetal and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Shivalik Bimetal and Krebs Biochemicals

Assuming the 90 days trading horizon Shivalik Bimetal Controls is expected to generate 0.72 times more return on investment than Krebs Biochemicals. However, Shivalik Bimetal Controls is 1.39 times less risky than Krebs Biochemicals. It trades about 0.05 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about 0.01 per unit of risk. If you would invest  38,507  in Shivalik Bimetal Controls on October 10, 2024 and sell it today you would earn a total of  20,458  from holding Shivalik Bimetal Controls or generate 53.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.79%
Values	Daily Returns

Shivalik Bimetal Controls  vs.  Krebs Biochemicals and

Shivalik Bimetal Controls

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shivalik Bimetal Controls has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Krebs Biochemicals and

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Shivalik Bimetal and Krebs Biochemicals

The main advantage of trading using opposite Shivalik Bimetal and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shivalik Bimetal position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.

The idea behind Shivalik Bimetal Controls and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.